BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16967621)

  • 1. 10 ways to create shareholder value.
    Rappaport A
    Harv Bus Rev; 2006 Sep; 84(9):66-77, 155. PubMed ID: 16967621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M&A needn't be a loser's game.
    Selden L; Colvin G
    Harv Bus Rev; 2003 Jun; 81(6):70-9, 137. PubMed ID: 12800718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFOs and strategists: forging a common framework.
    Rappaport A
    Harv Bus Rev; 1992; 70(3):84-91. PubMed ID: 10118005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. If private equity sized up your business.
    Pozen RC
    Harv Bus Rev; 2007 Nov; 85(11):78-87, 152. PubMed ID: 18159788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divestiture: strategy's missing link.
    Dranikoff L; Koller T; Schneider A
    Harv Bus Rev; 2002 May; 80(5):74-83, 133. PubMed ID: 12024760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How much cash does your company need?
    Passov R
    Harv Bus Rev; 2003 Nov; 81(11):119-22, 124-6, 128, 140. PubMed ID: 14619157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovation killers: how financial tools destroy your capacity to do new things.
    Christensen CM; Kaufman SP; Shih WC
    Harv Bus Rev; 2008 Jan; 86(1):98-105, 137. PubMed ID: 18271321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is a share buyback right for your company?
    Pettit J
    Harv Bus Rev; 2001 Apr; 79(4):141-7, 170. PubMed ID: 11299690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The staying power of the public corporation.
    Rappaport A
    Harv Bus Rev; 1990; 68(1):96-104. PubMed ID: 10103814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expensing options solves nothing.
    Sahlman WA
    Harv Bus Rev; 2002 Dec; 80(12):90-6, 134. PubMed ID: 12510541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative value of growth.
    Mass NJ
    Harv Bus Rev; 2005 Apr; 83(4):102-12, 134. PubMed ID: 15807043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capital versus talent. The battle that's reshaping business.
    Martin RL; Moldoveanu MC
    Harv Bus Rev; 2003 Jul; 81(7):36-41, 116. PubMed ID: 12858709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth crisis--and how to escape it.
    Slywotzky AJ; Wise R
    Harv Bus Rev; 2002 Jul; 80(7):72-83, 125. PubMed ID: 12140856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making sense of corporate venture capital.
    Chesbrough HW
    Harv Bus Rev; 2002 Mar; 80(3):90-9, 133. PubMed ID: 11894386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sharpening the intangibles edge.
    Lev B
    Harv Bus Rev; 2004 Jun; 82(6):109-16, 138. PubMed ID: 15202292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value acceleration: lessons from private-equity masters.
    Rogers P; Holland T; Haas D
    Harv Bus Rev; 2002 Jun; 80(6):94-101, 153. PubMed ID: 12048998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. You have more capital than you think.
    Merton RC
    Harv Bus Rev; 2005 Nov; 83(11):84-94, 166. PubMed ID: 16299963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The earnings game. Everyone plays, nobody wins.
    Collingwood H
    Harv Bus Rev; 2001 Jun; 79(6):65-7, 70-4, 146. PubMed ID: 11408978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to invest in social capital.
    Prusak L; Cohen D
    Harv Bus Rev; 2001 Jun; 79(6):86-93, 147. PubMed ID: 11408980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are you paying too much for that acquisition?
    Eccles RG; Lanes KL; Wilson TC
    Harv Bus Rev; 1999; 77(4):136-46, 186. PubMed ID: 10539205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.